A treatment for advanced hepatocellular carcinoma, the most common type of primary liver cancer, is to be covered by National Health Insurance (NHI) from Tuesday next week, the National Health Insurance Administration said yesterday.
Medical Review and Pharmaceutical Benefits Division head Huang Yu-wen (黃育文) said the policy covering atezolizumab plus bevacizumab combination therapy is expected to benefit 2,072 people with advanced liver cancer, allowing them to save about NT$3 million (US$95,688) in annual medical expenses.
In 2019, the NHI included three types of immune checkpoint inhibitors — nivolumab, pembrolizumab and atezolizumab — for the treatment of eight types of cancers, including liver cancer.
Photo: CNA
However, immunotherapy for liver cancer was removed from the list the following year, as NHI funding is limited and studies at the time suggested that its efficacy was not significantly better than targeted therapy, Huang said.
As more studies were conducted and clinical data collected, some countries approved the combination of atezolizumab, an immunotherapy drug, with bevacizumab, a targeted therapy drug, as the standard of care for first-line systemic therapy for advanced hepatocellular carcinoma, she said.
A study published last year showed that the median overall survival was 5.8 months longer in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab than those treated with sorafenib, a targeted therapy drug, she said.
Huang said that as the combination therapy has been adopted as the standard first-line therapy for treating advanced hepatocellular carcinoma in clinical treatment guidelines, and considering the clinical evidence and benefits to people with liver cancer, the Pharmaceutical Benefit and Reimbursement Scheme Joint Committee on June 15 approved the inclusion of the treatment in the NHI system.
Nipah virus infection is to be officially listed as a category 5 notifiable infectious disease in Taiwan in March, while clinical treatment guidelines are being formulated, the Centers for Disease Control (CDC) said yesterday. With Nipah infections being reported in other countries and considering its relatively high fatality rate, the centers on Jan. 16 announced that it would be listed as a notifiable infectious disease to bolster the nation’s systematic early warning system and increase public awareness, the CDC said. Bangladesh reported four fatal cases last year in separate districts, with three linked to raw date palm sap consumption, CDC Epidemic Intelligence
Two Taiwanese prosecutors were questioned by Chinese security personnel at their hotel during a trip to China’s Henan Province this month, the Mainland Affairs Council (MAC) said yesterday. The officers had personal information on the prosecutors, including “when they were assigned to their posts, their work locations and job titles,” MAC Deputy Minister and spokesman Liang Wen-chieh (梁文傑) said. On top of asking about their agencies and positions, the officers also questioned the prosecutors about the Cross-Strait Joint Crime-Fighting and Judicial Mutual Assistance Agreement, a pact that serves as the framework for Taiwan-China cooperation on combating crime and providing judicial assistance, Liang
Reports of Taiwanese going missing, being detained or interrogated, or having their personal liberties restricted in China increased about fourfold annually last year, the Mainland Affairs Council (MAC) said yesterday. Last year, 221 Taiwanese who traveled to China were reported missing, were detained and interrogated, or otherwise had their personal freedom restricted, up from 55 the previous year, the council said. Reopening group tours to China would be risky, as it would leave travelers with no way to seek help through official channels after Beijing shut down dialogue between the associations tasked with handling cross-strait tourism, the MAC said. Taipei’s Taiwan Strait Tourism
SHIFT: Taiwan is evolving from a transit stop into a tourist destination, with more international travelers willing to spend on tours, dining and cultural activities Taiwan rose three places in the World Tourism Barometer to 36th globally in 2024, with international tourism revenue of US$10.028 billion, the Tourism Administration said on Monday. The UN Tourism Organization publication said that its focus has switched from whether a country has returned to pre-COVID-19 levels of tourism to the amount spent by a tourist during an overseas trip. The nation last year welcomed 8.57 million international tourists, about 9 percent more than in 2024, with most tourists coming from Japan, South Korea, and Hong Kong and Macau, all of which accounted for at least 1 million tourists each. During the first
RSS